Dana Farber Cancer Institute /ID# 168782

Boston, Massachusetts 02215

We've found

1 trials

at this facility

A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Subjects With Advanced Solid Tumors.

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Boston, MA

Use our guide to learn which trials are right for you!